These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 36781361)

  • 21. Inhibition of PI3K/Akt signaling suppresses epithelial-to-mesenchymal transition in hepatocellular carcinoma through the Snail/GSK-3/beta-catenin pathway.
    Lee S; Choi EJ; Cho EJ; Lee YB; Lee JH; Yu SJ; Yoon JH; Kim YJ
    Clin Mol Hepatol; 2020 Oct; 26(4):529-539. PubMed ID: 32829570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secretory clusterin promotes hepatocellular carcinoma progression by facilitating cancer stem cell properties via AKT/GSK-3β/β-catenin axis.
    Zheng W; Yao M; Wu M; Yang J; Yao D; Wang L
    J Transl Med; 2020 Feb; 18(1):81. PubMed ID: 32059741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knockdown of DDX46 suppresses the proliferation and invasion of gastric cancer through inactivating Akt/GSK-3β/β-catenin pathway.
    Chen L; Xu M; Zhong W; Hu Y; Wang G
    Exp Cell Res; 2021 Feb; 399(1):112448. PubMed ID: 33347858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway.
    Qin CD; Ma DN; Ren ZG; Zhu XD; Wang CH; Wang YC; Ye BG; Cao MQ; Gao DM; Tang ZY
    Oncol Rep; 2017 Mar; 37(3):1725-1735. PubMed ID: 28112375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum-and-glucocorticoid-inducible-kinase-2 is overexpressed and mediates glycogen synthase kinase-3β/ β-catenin signal transduction in hepatocellular carcinoma].
    Liu JY; Kong X; Li H; Fan GL; Liu Y; Liang ZL; Wang LH; Zhang Y; Zhao Y; Fan YM; Wu B
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):43-46. PubMed ID: 32023698
    [No Abstract]   [Full Text] [Related]  

  • 26. Extracellular 5'-nucleotidase (CD73) promotes human breast cancer cells growth through AKT/GSK-3β/β-catenin/cyclinD1 signaling pathway.
    Yu J; Wang X; Lu Q; Wang J; Li L; Liao X; Zhu W; Lv L; Zhi X; Yu J; Jin Y; Zou Q; Ou Z; Liu X; Zhou P
    Int J Cancer; 2018 Mar; 142(5):959-967. PubMed ID: 29047106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth differentiation factor 15 induces growth and metastasis of human liver cancer stem-like cells via AKT/GSK-3β/β-catenin signaling.
    Xu Q; Xu HX; Li JP; Wang S; Fu Z; Jia J; Wang L; Zhu ZF; Lu R; Yao Z
    Oncotarget; 2017 Mar; 8(10):16972-16987. PubMed ID: 28199981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1α.
    Zhao J; Lin E; Cai C; Zhang M; Li D; Cai S; Zeng G; Yin Z; Wang B; Li P; Hong X; Chen J; Zou B; Li J
    Drug Des Devel Ther; 2022; 16():3197-3213. PubMed ID: 36158238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
    Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
    J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lectin BS-I inhibits cell migration and invasion via AKT/GSK-3β/β-catenin pathway in hepatocellular carcinoma.
    Jian Q; Yang Z; Shu J; Liu X; Zhang J; Li Z
    J Cell Mol Med; 2018 Jan; 22(1):315-329. PubMed ID: 28922551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice.
    Zhang ZJ; Yang YK; Wu WZ
    J Transl Med; 2014 Feb; 12():57. PubMed ID: 24581171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes.
    Cui J; Zhou X; Liu Y; Tang Z; Romeih M
    J Gastroenterol Hepatol; 2003 Mar; 18(3):280-7. PubMed ID: 12603528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PGC-1α Regulates Cell Proliferation and Invasion
    Yun SH; Park JI
    Anticancer Res; 2020 Feb; 40(2):653-664. PubMed ID: 32014906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of GSK-3beta promotes survival and proliferation of megakaryocytic cells through a beta-catenin-independent pathway.
    Soda M; Willert K; Kaushansky K; Geddis AE
    Cell Signal; 2008 Dec; 20(12):2317-23. PubMed ID: 18804163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma.
    Seo SH; Cho KJ; Park HJ; Lee HW; Kim BK; Park JY; Kim DY; Ahn SH; Cheon JH; Yook JI; Kim MD; Joo DJ; Kim SU
    Cell Commun Signal; 2023 Nov; 21(1):339. PubMed ID: 38012711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cleavage and polyadenylation-specific factor 3 induces cell cycle arrest via PI3K/Akt/GSK-3β signaling pathways and predicts a negative prognosis in hepatocellular carcinoma.
    Li N; Jiang S; Fu R; Lv J; Yao J; Mai J; Hua X; Chen H; Liu J; Lu M
    Biomark Med; 2021 Apr; 15(5):347-358. PubMed ID: 33666519
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
    Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
    Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-582-3p targeting ribonucleotide reductase regulatory subunit M2 inhibits the tumorigenesis of hepatocellular carcinoma by regulating the Wnt/β-catenin signaling pathway.
    Xu H; Li B
    Bioengineered; 2022 May; 13(5):12876-12887. PubMed ID: 35609318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. POTEE stimulates the proliferation of pancreatic cancer by activating the PI3K/Akt/GSK-3β/β-catenin signaling.
    Hao Q; Gao L; Niu W; Chen L; Zhang P; Chen Z
    Biofactors; 2020 Jul; 46(4):685-692. PubMed ID: 32589786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LAIR1-mediated resistance of hepatocellular carcinoma cells to T cells through a GSK-3β/β-catenin/MYC/PD-L1 pathway.
    Pan B; Ke X; Qiu J; Ye D; Zhang Z; Zhang X; Luo Y; Yao Y; Wu X; Wang X; Tang N
    Cell Signal; 2024 Mar; 115():111039. PubMed ID: 38199599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.